LJHT
ITCI

Laurie J. Hall Trustee’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Laurie J. Hall Trustee’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-70
Closed -$4K – 329
2022
Q4 		$4K Sell
70
-45
-39% -$2.25K ﹤0.01% 268
2022
Q3 		$5K Sell
115
-55
-32% -$2.87K ﹤0.01% 284
2022
Q2 		$10K Hold
170
– – ﹤0.01% 267
2022
Q1 		$10K Buy
170
+10
+6% +$519 ﹤0.01% 279
2021
Q4 		$8K Hold
160
– – ﹤0.01% 286
2021
Q3 		$6K Sell
160
-110
-41% -$3.82K ﹤0.01% 296
2021
Q2 		$11K Hold
270
– – ﹤0.01% 283
2021
Q1 		$9K Hold
270
– – ﹤0.01% 293
2020
Q4 		$9K Hold
270
– – ﹤0.01% 284
2020
Q3 		$7K Buy
+270
New +$6.16K ﹤0.01% 281

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Laurie J. Hall Trustee's ITCI Position: Q1 2023 in Review

Laurie J. Hall Trustee sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2023, closing a stake of 70 shares — an estimated $4K sold.

Laurie J. Hall Trustee first reported a position in ITCI in Q3 2020 and held it in 10 quarters. The position peaked at $11K in Q2 2021. 274 funds tracked by Wall St. Rank hold ITCI as of Q1 2023.

  • Laurie J. Hall Trustee reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2023 after selling out during the quarter.
  • Laurie J. Hall Trustee sold 70 Intra-Cellular Therapies Inc. shares in Q1 2023, an estimated $4K.
  • Laurie J. Hall Trustee first reported a position in Intra-Cellular Therapies Inc. in Q3 2020 and held it in 10 quarters.
  • Laurie J. Hall Trustee's Intra-Cellular Therapies Inc. position peaked at $11K in Q2 2021.
  • 274 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2023.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2023, filed 7 Apr 2023.